The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
Metabolic Syndrome and Related Disorders - United States
doi 10.1089/met.2015.0038
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Mary Ann Liebert Inc